Evidence map›Paper›PMID 38213717›Full record

ArticleJournal of Cancer2024

Integrated Multi-omics Analyses Identify CDCA5 as a Novel Biomarker Associated with Alternative Splicing, Tumor Microenvironment, and Cell Proliferation in Colon Cancer Via Pan-cancer Analysis.

Xinyue Bao, Xin Leng, Tianyu Yu, Junzheya Zhu, Yunhan Zhao, Tenzindrogar, Zhiluo Yang, Shaobo Wu, Qi Sun

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Xinyue BaoDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Xin LengDepartment of Urology, Affiliated Kunshan Hospital of Jiangsu University, Suzhou215300, China.
Tianyu YuDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Junzheya ZhuDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Yunhan ZhaoDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
TenzindrogarDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Zhiluo YangDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Shaobo WuDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Qi SunDepartment of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
First Affiliated Hospital of Xi'an Jiaotong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerCDCA5pan-cancer analysisprognosisTCGA

Identifiers

PMID38213717
PMCPMC10777042
OpenAlexW4390697893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.